Patients with type 2 diabetes receiving poor control while taking sulfonylurea improve more by adding inhaled insulin vs metformin, according to the results of an open-label, randomized study,

A novel category of oral antidiabetic agents that increase glucagon synthesis and improve beta cell function are showing “robust efficacy” and “placebo-like tolerability,” in the words of one investigator.

A protein kinase C-beta inhibitor reduced the risk of sustained vision loss and progression of diabetic macular edema in two phase III trials, researchers announced.

Regular physical exercise is one of the most important factors predicting glycemic control in children with type 1 diabetes mellitus (T1DM), according to the results of a cross-sectional analysis.

Adolescents with type 1 diabetes consume fewer calories from carbohydrates but more calories from fat than adolescents without diabetes and exceed the recommended levels of fat intake, which increases the risk for cardiovascular disease.

Lowering blood levels of a protein found in higher quantities among those with insulin resistance might cut the risk of diabetes, metabolic syndrome and cardiovascular disease, a new study suggests. Raised levels of the protein in the blood may provide an early warning sign of the development of type 2 …

Pfizer is buying exclusive worldwide rights to an experimental class of Bayer obesity drugs.

The International Diabetes Federation (IDF) has put India, along with China and the U.S., on notice as the spread of diabetes worldwide is assuming alarming proportions.

Death was 15 times more likely in patients with hyperglycemia, with just one milligram per declliter above normal

According to new research presented at ADA, after more than half a century of living with type 1 diabetes, a significant number of patients appear to have residual beta-islet cell function.